Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending February 23, 2020 Psoriasis Elevates Cancer Risk, Anti–TNF-Alpha Nonresponse in AxSpA Predicted by Socioeconomic, Patient-Reported Factors, Value of Very Early Etanercept Plus Methotrexate Not Confirmed in Real-World RA Trial, Multiple Assessment Measures Can Hone RA Treatment, TNFi Monotherapy Remains Feasible for Older Rheumatoid Arthritis Patients, More must reads Must reads for theWeek ending February 16, 2020 Tramadol Use for Noncancer Pain Linked With Increased Hip Fracture Risk, Fast-Tracked Surgery for Hip Fracture Does Not Reduce Mortality, Meta-Analysis Eyes Impact of Adherence to HCQ Among SLE Patients, More must readsMust reads for theWeek ending February 9, 2020 Hypertensive Disorders of Pregnancy in SLE Contribute to Later CV Outcomes, Physician Groups Push Back on Medicaid Block Grant Plan, More must readsMust reads for theWeek ending February 2, 2020 Zoledronate Promotes Postdenosumab Bone Retention, Costs Are Keeping Americans Out of the Doctor’s Office, Registry Data Reveal Temporal Relationship Between Psoriasis Symptoms and PsA Onset, Human Cytomegalovirus Seropositivity Linked to Less Bone Erosion in RA Patients, Driving Skills Remain Underassessed in RA Patients, More must readsMust reads for theWeek ending January 26, 2020 Apremilast More Likely to Succeed With Moderate Psoriatic Arthritis Activity, TNFi Treatment Shows Hint of Slowing Axial Spondyloarthritis Radiographic Progression, What Happens to Clinically Suspected Arthralgia Patients Without RA?, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 last »
